Analytical Data
-
基因名
OsI
- Application
-
别名
OsI；APETALA2-like Protein 5
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q13501
-
表达区间
1-35aa
-
氨基酸序列
MAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMVHPNVICDGCNGPVVGTRYKCSV CPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPG NWSPRPPRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGK RSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNVEGATQSLAEQMRKIALESEGRPEE QMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYP HLPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKHPPPL
-
分子量
47.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The OSI (Oncogenic Signal Induction) recombinant proteins have garnered significant attention in the field of cancer research due to their potential role in the modulation of signaling pathways that contribute to tumorigenesis. These proteins are often derived from oncogenes, which are genes that have the potential to cause cancer when mutated or expressed at high levels. Studies have shown that aberrant activation of OSI proteins can lead to uncontrolled cell proliferation, evasion of apoptosis, and metastasis, making them pivotal in understanding the mechanisms of cancer development. Recombinant technology allows researchers to produce these proteins in controlled environments, facilitating the study of their biochemical properties and interactions. This research background underscores the importance of OSI recombinant proteins not only in elucidating the molecular underpinnings of cancer but also in the development of targeted therapies. By manipulating these proteins, scientists aim to uncover novel therapeutic strategies and improve treatment outcomes for cancer patients, emphasizing their relevance in modern oncology.
